Atara's Ebvallo Receives European Commission Approval For Adults And Children With EBV+ PTLD

RTTNews | 864 days ago
Stocktwits
Atara's Ebvallo Receives European Commission Approval For Adults And Children With EBV+ PTLD

(RTTNews) - Atara Biotherapeutics, Inc. (ATRA) and French healthcare company Pierre Fabre announced Monday that the European Commission (EC) has granted marketing authorization for Ebvallo (tabelecleucel) as a monotherapy for the treatment of adult and pediatric patients two years of age and older with relapsed or refractory Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD) who have received at least one prior therapy.

For solid organ transplant patients, prior therapy includes chemotherapy unless chemotherapy is inappropriate.

The approval follows a positive opinion in October by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) and is applicable to all 27 European Union member states plus Iceland, Norway, and Liechtenstein.

The CHMP positive opinion is based on results from the pivotal Phase 3 ALLELE study. In this study, Ebvallo demonstrated a favorable risk-benefit profile.

EBV+ PTLD is a rare, acute, and potentially deadly hematologic malignancy that occurs after transplantation when a patient's T-cell immune response is compromised by immunosuppression.

Under a previously announced License Agreement with Atara, Pierre Fabre will lead all commercialization and distribution activities in Europe and select other markets, in addition to medical and regulatory activities following the transfer of the Ebvallo Marketing Authorization Application (MAA) to Pierre Fabre from Atara.

Ebvallo has orphan designation in Europe.

For More Such Health News, visit rttnews.com

Tags: ATRA
Stocktwits
read more
Yen Slides As Bank Of Japan Retains Rate As Expected

Yen Slides As Bank Of Japan Retains Rate As Expected

The Japanese yen weakened against other major currencies in the Asian session on Thursday, after the Bank of Japan left its interest rate unchanged for the second consecutive meeting and downgraded its growth projections citing trade tariff threats.
RTTNews | 1h 47min ago
Commodity Currencies Rise Amid Risk-on Mood

Commodity Currencies Rise Amid Risk-on Mood

The commodity currencies such as Australia, the New Zealand and the Canadian dollars strengthened against their major currencies in the Asian session on Thursday amid increased risk-on mood, as traders booked some profits after the recent upside in markets and a report showing the U.S. economy unexpectedly shrank in the first three months of 2025 generated some optimism about the outlook for interest rates.
RTTNews | 2h 2min ago
Yen Slides Against Majors

Yen Slides Against Majors

The Japanese yen strengthened against other major currencies in the Asian session on Thursday.
RTTNews | 3h 12min ago
Bank Of Japan Retains Rate As Expected; Cuts Growth Outlook Amid Tariff Uncertainty

Bank Of Japan Retains Rate As Expected; Cuts Growth Outlook Amid Tariff Uncertainty

The Bank of Japan left its interest rate unchanged for the second consecutive meeting on Thursday, and downgraded its growth projections citing trade tariff threats. The policy board decided, by a unanimous vote, to hold the uncollateralized overnight call rate to remain at around 0.50 percent. This was the highest level since the global financial crisis in 2008.
RTTNews | 3h 13min ago
European Economic News Preview: UK Mortgage Approvals, Factory PMI Due

European Economic News Preview: UK Mortgage Approvals, Factory PMI Due

Mortgage approvals and final manufacturing Purchasing Managers' survey results from the UK are the major reports due on Thursday, while most of the European markets are closed for the Labor day holiday. At 2.30 am ET, Switzerland's Federal Statistical Office releases retail sales data for March. Sales are forecast o grow 1.9 percent on a yearly basis, following a 1.6 percent rise in February.
RTTNews | 3h 38min ago
Tools
Economic Calendar
Market Hours
Interest Rates
Holidays Calendar
Forex Market
Forex Volatility
Forex Correlation
Forex News
forex analysis
COT Data
Liquidity
Forex Calculators
Forex Heat Map
Indicators Heatmap
Community
Community
Systems
Most Popular Systems
Strategies
Contests
Forex Charts
Forex Sentiment
Sentiment Indicator
Reviews
Brokers
Prop Trading Firms
VPS Services
Signal Providers
EA Programming Services
Affiliate Programs
PAMM Broker Services
Rebate Program Services
Trading Platforms
Expert Advisors
Crypto Exchanges
Trading Courses
Brokers
Forex Spreads
Forex Broker Quotes
Forex Broker Swaps
Forex Broker Volume
Forex Broker Promotions Press Release
Platform
Widgets
Features
API
RSS
Stock Portfolio
Affiliate Software
Advanced Charts
Support
FAQ
Help
Contact Us
Report a Bug!
About
Blog
© 2025 Myfxbook Ltd. All Rights Reserved.
HIGH RISK WARNING: Foreign exchange trading carries a high level of risk that may not be suitable for all investors. Leverage creates additional risk and loss exposure. Before you decide to trade foreign exchange, carefully consider your investment objectives, experience level, and risk tolerance. You could lose some or all of your initial investment. Do not invest money that you cannot afford to lose. Educate yourself on the risks associated with foreign exchange trading, and seek advice from an independent financial or tax advisor if you have any questions. Any data and information is provided 'as is' solely for informational purposes, and is not intended for trading purposes or advice. Past performance is not indicative of future results.